Client was looking for a pricing and reimbursement econometric model. Problem was to communicate efficacy and additional benefits of a new anti-depression drug. Our user friendly interactive software model allowed users with no health economic background to easily understand efficacy of a new drug and additional benefits for patients.
Danish, German, Turkish Government approved a new drug for 100% coverage.